These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 18301795

  • 1. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term adaptive changes induced by serotonergic antidepressant drugs.
    Faure C, Mnie-Filali O, Haddjeri N.
    Expert Rev Neurother; 2006 Feb; 6(2):235-45. PubMed ID: 16466303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glutamate-based antidepressants: 20 years on.
    Skolnick P, Popik P, Trullas R.
    Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
    [Abstract] [Full Text] [Related]

  • 9. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY, Huang M.
    Prog Brain Res; 2008 Nov; 172():177-97. PubMed ID: 18772033
    [Abstract] [Full Text] [Related]

  • 10. A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.
    Witkin JM, Tzavara ET, Davis RJ, Li X, Nomikos GG.
    Trends Pharmacol Sci; 2005 Dec; 26(12):609-17. PubMed ID: 16260047
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Strategies for producing faster acting antidepressants.
    Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F.
    Drug Discov Today; 2005 Apr 15; 10(8):578-85. PubMed ID: 15837601
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response.
    Blier P.
    J Psychiatry Neurosci; 2001 Apr 15; 26 Suppl(Suppl):S3-10. PubMed ID: 11590967
    [Abstract] [Full Text] [Related]

  • 18. Beyond serotonin.
    Meltzer HY.
    J Clin Psychiatry; 1991 May 15; 52 Suppl():58-62. PubMed ID: 2030105
    [Abstract] [Full Text] [Related]

  • 19. Rational site-directed pharmacotherapy for major depressive disorder.
    Blier P.
    Int J Neuropsychopharmacol; 2014 Jul 15; 17(7):997-1008. PubMed ID: 23745670
    [Abstract] [Full Text] [Related]

  • 20. [Affective disorders and antidepressant drugs: Therapeutic innovations].
    Fakra E, Azorin JM, Adida M, Da Fonseca D, Kaladjian A, Pringuey D.
    Encephale; 2010 Dec 15; 36 Suppl 6():S183-7. PubMed ID: 21237354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.